Results for "gastrointestinal problems"
Conditions Encyclopedia Entry 1775298066
Mitochondrial myopathies are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells, leading to muscle weakness, fatigue, and other systemic symptoms.
Health & MedicineConditions Encyclopedia Entry 1776913205
Mitochondrial myopathies are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells, leading to muscle weakness, fatigue, and other systemic symptoms.
Health & MedicineConditions Encyclopedia Entry 1777230006
Mitochondrial myopathies are a group of rare genetic disorders affecting the mitochondria, leading to muscle weakness, fatigue, and other systemic symptoms.
Health & MedicineConditions Encyclopedia Entry 1777837455
** **Mitochondrial Myopathies** are a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells, leading to muscle weakness, fatigue, and other systemic symptoms. **CONTENT:** ### Overview Mitochondrial myopathies are a complex and heterogeneous group of disorders caused by mutations in the mitochondrial DNA (mtDNA) or nuclear DNA (nDNA) that affect the mitochondria's ability to produce energy. Mitochondria are the powerhouses of cells, responsible for generating most of the energy required for cellular functions. In mitochondrial myopathies, the mitochondria are unable to produce sufficient energy, leading to a range of symptoms, including muscle weakness, fatigue, and other systemic problems. These disorders can affect individuals of all ages, from infancy to adulthood. Mitochondrial myopathies are often inherited in an autosomal dominant or maternal pattern, meaning that a single copy of the mutated gene is sufficient to cause the disorder. The symptoms and severity of the disorder can vary widely among affected individuals, even within the same family. Some individuals may experience mild symptoms, while others may have more severe and debilitating symptoms. ### History/Background The first reported cases of mitochondrial myopathies date back to the 1960s, when researchers identified a group of patients with a rare disorder characterized by muscle weakness, fatigue, and other systemic symptoms. Over the years, researchers have made significant progress in understanding the genetic and molecular mechanisms underlying these disorders. In 1988, the first mitochondrial DNA mutation was identified as the cause of a mitochondrial myopathy. Since then, numerous other mutations have been identified, and the field has continued to evolve with advances in genetic testing and molecular biology. ### Key Information Mitochondrial myopathies can be caused by mutations in either the mitochondrial DNA or nuclear DNA. The most common types of mitochondrial myopathies include: * **Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes (MELAS)**: a disorder characterized by muscle weakness, seizures, and stroke-like episodes. * **Myoclonic Epilepsy with Ragged-Red Fibers (MERRF)**: a disorder characterized by muscle weakness, seizures, and ragged-red fibers in muscle biopsies. * **Kearns-Sayre Syndrome (KSS)**: a disorder characterized by muscle weakness, heart problems, and vision loss. * **Leber Hereditary Optic Neuropathy (LHON)**: a disorder characterized by vision loss and blindness. Symptoms of mitochondrial myopathies can vary widely, but may include: * Muscle weakness and fatigue * Seizures and epilepsy * Vision loss and blindness * Heart problems and arrhythmias * Gastrointestinal problems * Developmental delays and intellectual disability ### Significance Mitochondrial myopathies are a significant cause of morbidity and mortality worldwide. These disorders can have a profound impact on an individual's quality of life, causing significant disability and suffering. While there is currently no cure for mitochondrial myopathies, researchers are working to develop new treatments and therapies to alleviate symptoms and improve quality of life. **INFOBOX:** - **Name:** Mitochondrial Myopathies - **Type:** Genetic disorder - **Date:** First reported cases in the 1960s - **Location:** Global - **Known For:** Rare genetic disorders affecting the mitochondria **TAGS:** Mitochondrial myopathies, genetic disorders, mitochondrial DNA, nuclear DNA, muscle weakness, fatigue, seizures, vision loss, heart problems, gastrointestinal problems, developmental delays, intellectual disability.
Health & MedicineConditions Encyclopedia Entry 1776503465
** This entry is about the condition known as **Ehlers-Danlos Syndrome (EDS)**, a group of genetic disorders that affect the body's connective tissue. ## Overview Ehlers-Danlos Syndrome (EDS) is a rare genetic disorder characterized by extremely flexible joints, skin hyperextensibility, and tissue fragility. It affects approximately 1 in 5,000 to 1 in 20,000 people worldwide. EDS is often misunderstood, and its symptoms can vary greatly from person to person, making diagnosis challenging. The condition is named after the two doctors who first described it, Edvard Ehlers and Henri-Alexandre Danlos. People with EDS may experience a range of symptoms, including joint instability, easy bruising, and poor wound healing. They may also have a higher risk of developing other conditions, such as gastrointestinal problems, cardiovascular issues, and osteoporosis. While EDS is primarily a genetic disorder, environmental factors can also contribute to its development. ## History/Background The first reported case of EDS was in 1892 by the Danish dermatologist Edvard Ehlers. He described a patient with extremely flexible joints and fragile skin. Later, in 1908, the French dermatologist Henri-Alexandre Danlos wrote a paper about a similar condition, which he called "cutis hyperelastica." The two doctors' work laid the foundation for the understanding of EDS as a distinct medical condition. Over the years, researchers have identified several subtypes of EDS, each with its unique set of symptoms and characteristics. The most common subtypes are Classical EDS (cEDS), Hypermobile EDS (hEDS), and Vascular EDS (vEDS). While the exact cause of EDS is still not fully understood, it is believed to result from mutations in genes that code for collagen, a protein essential for connective tissue. ## Key Information EDS is a complex condition that affects various aspects of a person's life. Some key facts about EDS include: * **Genetic inheritance**: EDS is inherited in an autosomal dominant pattern, meaning that a single copy of the mutated gene is enough to cause the condition. * **Symptom variability**: The severity and type of symptoms can vary greatly from person to person, even within the same family. * **Diagnostic challenges**: EDS can be difficult to diagnose, as its symptoms are often similar to those of other conditions. * **Comorbidities**: People with EDS are at a higher risk of developing other conditions, such as gastrointestinal problems, cardiovascular issues, and osteoporosis. * **Treatment options**: While there is no cure for EDS, various treatments can help manage its symptoms, including physical therapy, pain management, and surgery. ## Significance EDS is a significant condition that affects not only the individual but also their family and caregivers. Understanding EDS is crucial for providing proper care and support to those affected. Some of the reasons why EDS matters include: * **Improved diagnosis**: Accurate diagnosis and early intervention can significantly improve the quality of life for people with EDS. * **Increased awareness**: Raising awareness about EDS can help reduce stigma and promote understanding among healthcare professionals and the general public. * **Advancements in research**: Continued research into EDS can lead to a better understanding of its causes and development of new treatments. INFOBOX: - **Name:** Ehlers-Danlos Syndrome (EDS) - **Type:** Genetic disorder - **Date:** 1892 (first reported case) - **Location:** Worldwide - **Known For:** Extremely flexible joints, skin hyperextensibility, and tissue fragility TAGS: Ehlers-Danlos Syndrome, genetic disorder, connective tissue, joint instability, skin hyperextensibility, tissue fragility, gastrointestinal problems, cardiovascular issues, osteoporosis, rare condition.
Health & MedicineConditions Encyclopedia Entry 1780261505
Ehlers-Danlos Syndrome (EDS) is a group of genetic disorders affecting the body's connective tissue, leading to fragile skin, joints, and blood vessels.
Health & MedicineConditions Encyclopedia Entry 1780645685
Sjögren's syndrome is a chronic autoimmune disorder characterized by inflammation and damage to the exocrine glands, particularly the salivary and lacrimal glands, leading to symptoms such as dry mouth and eyes.
Health & MedicineConditions Encyclopedia Entry 1780707066
** **Mitochondrial Myopathies** are a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells, leading to muscle weakness, fatigue, and other systemic symptoms. **CONTENT:** ### **Overview** Mitochondrial myopathies are a diverse group of disorders caused by mutations in the mitochondrial DNA, which affects the energy production within cells. These conditions are characterized by progressive muscle weakness, fatigue, and other systemic symptoms. Mitochondrial myopathies can affect individuals of all ages, from infancy to adulthood, and are often inherited in an autosomal dominant or maternal pattern. The symptoms and severity of the condition vary widely among individuals, making diagnosis and treatment challenging. Mitochondrial myopathies are a subset of mitochondrial disorders, which are estimated to affect approximately 1 in 5,000 individuals worldwide. The conditions are often associated with other systemic symptoms, including gastrointestinal, neurological, and cardiac problems. In some cases, mitochondrial myopathies can be life-threatening, particularly if left untreated or if the condition progresses rapidly. ### **History/Background** The first reported case of mitochondrial myopathy dates back to 1962, when a British physician, **John Morgan Hughes**, described a patient with a rare condition characterized by muscle weakness and fatigue. However, it wasn't until the 1980s that the genetic basis of mitochondrial myopathies was identified. The discovery of mutations in the mitochondrial DNA revolutionized the understanding of these conditions and paved the way for genetic testing and diagnosis. ### **Key Information** Mitochondrial myopathies are caused by mutations in the mitochondrial DNA, which affects the energy production within cells. The most common mutations associated with these conditions include: * **MELAS syndrome** (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes) * **MERRF syndrome** (Myoclonus Epilepsy with Ragged-Red Fibers) * **KSS syndrome** (Kearns-Sayre syndrome) * **NARP syndrome** (Neuropathy, Ataxia, and Retinitis Pigmentosa) Symptoms of mitochondrial myopathies can vary widely among individuals and may include: * **Muscle weakness** and fatigue * **Gastrointestinal problems**, such as diarrhea and abdominal pain * **Neurological symptoms**, including seizures and ataxia * **Cardiac problems**, including arrhythmias and cardiomyopathy * **Visual disturbances**, including blurred vision and loss of vision ### **Significance** Mitochondrial myopathies are a significant public health concern due to their rarity and the challenges associated with diagnosis and treatment. These conditions often require a multidisciplinary approach, involving geneticists, neurologists, cardiologists, and other specialists. Early diagnosis and treatment can significantly improve the quality of life for individuals with mitochondrial myopathies, but more research is needed to understand the underlying mechanisms of these conditions and to develop effective treatments. **INFOBOX:** - **Name:** Mitochondrial Myopathies - **Type:** Genetic disorder - **Date:** 1962 (first reported case) - **Location:** Worldwide - **Known For:** Rare genetic disorders affecting the mitochondria, leading to muscle weakness and systemic symptoms **TAGS:** Mitochondrial disorders, genetic disorders, muscle weakness, fatigue, gastrointestinal problems, neurological symptoms, cardiac problems, visual disturbances, rare diseases.